Profile | GDS5420 / 230904_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 350.76 | 61 |
GSM1296119 | B_lesional_pre-dose | 208.25 | 53 |
GSM1296076 | C_lesional_pre-dose | 358.22 | 63 |
GSM1296092 | D_lesional_pre-dose | 282.42 | 59 |
GSM1296103 | E_lesional_pre-dose | 254.18 | 56 |
GSM1296078 | F_lesional_pre-dose | 366.71 | 64 |
GSM1296107 | G_lesional_pre-dose | 197.16 | 51 |
GSM1296109 | H_lesional_pre-dose | 283.97 | 57 |
GSM1296080 | I_lesional_pre-dose | 805.65 | 75 |
GSM1296090 | J_lesional_pre-dose | 233.17 | 56 |
GSM1296074 | K_lesional_pre-dose | 365.46 | 64 |
GSM1296111 | L_lesional_pre-dose | 249.22 | 55 |
GSM1296099 | M_lesional_pre-dose | 360.8 | 62 |
GSM1296086 | O_lesional_pre-dose | 467.15 | 67 |
GSM1296117 | P_lesional_pre-dose | 199.79 | 51 |
GSM1296113 | Q_lesional_pre-dose | 158.02 | 46 |
GSM1296096 | R_lesional_pre-dose | 324.12 | 60 |
GSM1296105 | S_lesional_pre-dose | 479.57 | 67 |
GSM1296098 | T_lesional_pre-dose | 404.62 | 64 |
GSM1296101 | U_lesional_pre-dose | 360.2 | 62 |
GSM1296121 | V_lesional_pre-dose | 241.75 | 55 |
GSM1296088 | W_lesional_pre-dose | 581.44 | 70 |
GSM1296082 | X_lesional_pre-dose | 260.82 | 58 |
GSM1296115 | Y_lesional_pre-dose | 154.85 | 47 |
GSM1296084 | Z_lesional_pre-dose | 504.3 | 68 |
GSM1296072 | B_lesional_day8 | 245.98 | 55 |
GSM1296069 | L_lesional_day8 | 269.53 | 56 |
GSM1296071 | P_lesional_day8 | 317.14 | 59 |
GSM1296070 | Y_lesional_day8 | 208.67 | 51 |
GSM1296073 | V_lesional_day8 | 189.99 | 52 |
GSM1296034 | A_lesional_day15 | 405.87 | 63 |
GSM1296041 | G_lesional_day15 | 184.88 | 51 |
GSM1296035 | R_lesional_day15 | 275.65 | 58 |
GSM1296038 | U_lesional_day15 | 480.81 | 67 |
GSM1296047 | B_lesional_day15 | 275.3 | 57 |
GSM1296039 | E_lesional_day15 | 222.39 | 54 |
GSM1296042 | H_lesional_day15 | 256.89 | 56 |
GSM1296043 | L_lesional_day15 | 346.33 | 61 |
GSM1296037 | M_lesional_day15 | 372.36 | 62 |
GSM1296046 | P_lesional_day15 | 193.29 | 50 |
GSM1296044 | Q_lesional_day15 | 189.12 | 49 |
GSM1296045 | Y_lesional_day15 | 259.54 | 55 |
GSM1296025 | C_lesional_day15 | 924.23 | 78 |
GSM1296033 | D_lesional_day15 | 519.4 | 68 |
GSM1296027 | I_lesional_day15 | 664.42 | 72 |
GSM1296032 | J_lesional_day15 | 564.58 | 69 |
GSM1296024 | K_lesional_day15 | 929.48 | 78 |
GSM1296031 | W_lesional_day15 | 587.8 | 70 |
GSM1296028 | X_lesional_day15 | 469.32 | 66 |
GSM1296029 | Z_lesional_day15 | 531.85 | 68 |
GSM1296026 | F_lesional_day15 | 720.92 | 74 |
GSM1296030 | O_lesional_day15 | 569.55 | 70 |
GSM1296040 | S_lesional_day15 | 280.57 | 58 |
GSM1296036 | T_lesional_day15 | 650.71 | 72 |
GSM1296048 | V_lesional_day15 | 268.85 | 57 |
GSM1296059 | A_lesional_day43 | 275.49 | 58 |
GSM1296066 | G_lesional_day43 | 262.96 | 56 |
GSM1296060 | R_lesional_day43 | 378.63 | 63 |
GSM1296063 | U_lesional_day43 | 362.07 | 62 |
GSM1296064 | E_lesional_day43 | 256.18 | 57 |
GSM1296067 | H_lesional_day43 | 395.79 | 63 |
GSM1296062 | M_lesional_day43 | 471.79 | 66 |
GSM1296068 | Q_lesional_day43 | 223.33 | 52 |
GSM1296050 | C_lesional_day43 | 737.78 | 74 |
GSM1296057 | D_lesional_day43 | 367.62 | 62 |
GSM1296052 | I_lesional_day43 | 605.87 | 71 |
GSM1296054 | J_lesional_day43 | 545.25 | 69 |
GSM1296049 | K_lesional_day43 | 849.47 | 76 |
GSM1296055 | W_lesional_day43 | 313.19 | 59 |
GSM1296053 | X_lesional_day43 | 565.1 | 69 |
GSM1296058 | Z_lesional_day43 | 387.18 | 63 |
GSM1296051 | F_lesional_day43 | 547.53 | 70 |
GSM1296056 | O_lesional_day43 | 358.02 | 63 |
GSM1296065 | S_lesional_day43 | 398.1 | 64 |
GSM1296061 | T_lesional_day43 | 691.03 | 73 |
GSM1296095 | A_non-lesional_pre-dose | 192.15 | 52 |
GSM1296120 | B_non-lesional_pre-dose | 240.4 | 54 |
GSM1296077 | C_non-lesional_pre-dose | 675.03 | 73 |
GSM1296093 | D_non-lesional_pre-dose | 476.58 | 66 |
GSM1296104 | E_non-lesional_pre-dose | 194.87 | 52 |
GSM1296079 | F_non-lesional_pre-dose | 788.12 | 75 |
GSM1296108 | G_non-lesional_pre-dose | 169.31 | 49 |
GSM1296110 | H_non-lesional_pre-dose | 278.1 | 56 |
GSM1296081 | I_non-lesional_pre-dose | 461.03 | 67 |
GSM1296091 | J_non-lesional_pre-dose | 280.7 | 59 |
GSM1296075 | K_non-lesional_pre-dose | 447.1 | 67 |
GSM1296112 | L_non-lesional_pre-dose | 429.9 | 64 |
GSM1296100 | M_non-lesional_pre-dose | 349.06 | 61 |
GSM1296087 | O_non-lesional_pre-dose | 533.16 | 69 |
GSM1296118 | P_non-lesional_pre-dose | 227.41 | 53 |
GSM1296114 | Q_non-lesional_pre-dose | 191.93 | 50 |
GSM1296097 | R_non-lesional_pre-dose | 389.17 | 63 |
GSM1296106 | S_non-lesional_pre-dose | 360.4 | 61 |
GSM1296102 | U_non-lesional_pre-dose | 513.27 | 67 |
GSM1296122 | V_non-lesional_pre-dose | 412.51 | 64 |
GSM1296089 | W_non-lesional_pre-dose | 413.84 | 64 |
GSM1296083 | X_non-lesional_pre-dose | 461.54 | 66 |
GSM1296116 | Y_non-lesional_pre-dose | 254.52 | 55 |
GSM1296085 | Z_non-lesional_pre-dose | 502.56 | 68 |